tlyA Resolved · high auto-curated

H37Rv Rv1694 · MTBC0 mtbc0_001802 · 268 aa · 1929955–1930761 MTBC0 (+) · RefSeq NP_216210.1

Genomic neighbourhood (genome browser)

Open in full genome browser →

This gene (outlined) in its genomic context; arrows are neighbouring genes coloured by verdict. Click any gene to navigate. Pan and zoom in the full browser.

Annotation: from legacy to revised

Legacy (H37Rv / Mycobrowser)16S/23S rRNA (cytidine-2'-O)-methyltransferase TlyA
MTBC0 PGAP re-annotation16S/23S rRNA (cytidine-2'-O)-methyltransferase TlyA
Revised (this work)16S/23S rRNA (cytidine-2'-O)-methyltransferase TlyA. Pfam: S4 (PF01479.31), FtsJ (PF01728.26).
Functional category (TubercuList)virulence, detoxification, adaptation

Auto-curated: this verdict and function were generated by rules from PGAP + Pfam + Foldseek and have not been hand-reviewed.

In the literature (TB corpus sweep) 82 publications

82 TB publications mention this gene. 82 publications discuss this gene. Queried separately, 77 records carry a M. tuberculosis context and 13 a non-TB mycobacterial context (species named in the 13-record verified sample: M. smegmatis (9), M. leprae (6), M. marinum (2)). The three counts come from three distinct PubMed queries (each with its own context filter), so they neither partition the total nor need to add up to it.

5 of 82: the most recently indexed records of the curated sweep at its date, not necessarily the most recent papers on this gene — the exhaustive list below is later and broader and may hold newer ones.
PublicationDate
TlyA is a 23S and 16S 2'-O-methylcytidine methyltransferase important for ribosome assembly in Bacillus subtilis. doi:10.1093/nar/gkaf1531 2026
Microevolutionary models and multi-omics analysis uncover the cross-drug resistance characteristics of capreomycin-selected Mycobacterium tuberculosis. doi:10.1016/j.crmicr.2025.100507 2025
Drug selection based on pan-genomics genetic features of Mycobacterium tuberculosis. doi:10.3389/fmicb.2025.1663069 2025
Distant ribose 2'-O-methylation of 23S rRNA helix 69 pre-orders the capreomycin drug binding pocket at the ribosome subunit interface. doi:10.1093/nar/gkaf618 2025
TlyA is a 23S and 16S 2'-O-methylcytidine methyltransferase important for ribosome assembly in Bacillus subtilis. doi:10.1101/2025.04.21.649808 2025
83 records returned by the alias sweep (a separate sweep from the 82 above; both are shown, neither is exhaustive)

Searched as: Rv1694, tlyA, Mb1720, ML1358, MMAR_2499, MSMEG_3751, MAB_2359 — each in conjunction with a mycobacterial context term. Swept 2026-09-07.

PublicationJournalYear
TlyA is a 23S and 16S 2'-O-methylcytidine methyltransferase important for ribosome assembly in Bacillus subtilis. doi:10.1093/nar/gkaf1531 names it Nucleic Acids Res 2026
Microevolutionary models and multi-omics analysis uncover the cross-drug resistance characteristics of capreomycin-selected Mycobacterium tuberculosis. doi:10.1016/j.crmicr.2025.100507 Curr Res Microb Sci 2025
Drug selection based on pan-genomics genetic features of Mycobacterium tuberculosis. doi:10.3389/fmicb.2025.1663069 Front Microbiol 2025
TlyA is a 23S and 16S 2'-O-methylcytidine methyltransferase important for ribosome assembly in Bacillus subtilis. doi:10.1101/2025.04.21.649808 names it bioRxiv 2025
Mycobacterium tuberculosis and its clever approaches to escape the deadly macrophage. doi:10.1007/s11274-023-03735-9 World J Microbiol Biotechnol 2023
Whole-genome sequencing reveals genotypic resistance in phenotypically susceptible Mycobacterium tuberculosis clinical isolates. doi:10.4103/ijmy.ijmy_101_23 Int J Mycobacteriol 2023
GenoType MTBDRsl for detection of second-line drugs and ethambutol resistance in multidrug-resistant Mycobacterium tuberculosis isolates at a high-throughput laboratory. doi:10.1016/j.diagmicrobio.2022.115856 Diagn Microbiol Infect Dis 2023
Genomic analysis of Mycobacterium tuberculosis variant bovis strains isolated from bovine in the state of Mato Grosso, Brazil. doi:10.3389/fvets.2022.1006090 Front Vet Sci 2022
Evaluation of Susceptibility of the Human Pathogen Helicobacter pylori to the Antibiotic Capreomycin. doi:10.1155/2022/8924023 ScientificWorldJournal 2022
[Exploratory study on detection of drug resistance of Mycobacterium tuberculosis in sputum specimens by next-generation sequencing]. doi:10.3760/cma.j.cn112147-20211104-00775 Zhonghua Jie He He Hu Xi Za Zhi 2022
Molecular Epidemiology and Polymorphism Analysis in Drug-Resistant Genes in M. tuberculosis Clinical Isolates from Western and Northern India. doi:10.2147/IDR.S345855 Infect Drug Resist 2022
50S subunit recognition and modification by the Mycobacterium tuberculosis ribosomal RNA methyltransferase TlyA. doi:10.1073/pnas.2120352119 names it Proc Natl Acad Sci U S A 2022
RNA Expression Analysis of Mycobacterial Methyltransferases Genes in Different Resistant Strains of Mycobacterium tuberculosis. doi:10.52547/ibj.26.3.240 Iran Biomed J 2022
Role of TlyA in the Biology of Uncultivable Mycobacteria. doi:10.2174/1386207325666220111150923 names it Comb Chem High Throughput Screen 2022
Insights into the mutations leading to capreomycin resistance in S-adenosyl-L-methionine binding motif in TlyA from Mycobacterium tuberculosis. doi:10.1080/07391102.2021.1969284 names it J Biomol Struct Dyn 2022
Whole genome sequencing reveals large deletions and other loss of function mutations in Mycobacterium tuberculosis drug resistance genes. doi:10.1099/mgen.0.000724 Microb Genom 2021
Molecular characterization of mutations associated with resistance to second line drugs in Mycobacterium tuberculosis patients from Casablanca, Morocco. doi:10.1590/S1678-9946202163019 Rev Inst Med Trop Sao Paulo 2021
Sequence-based detection of first-line and second-line drugs resistance-associated mutations in Mycobacterium tuberculosis isolates in Isfahan, Iran. doi:10.1016/j.meegid.2020.104468 Infect Genet Evol 2020
Virulence properties of Campylobacter jejuni are enhanced by displaying a mycobacterial TlyA methylation pattern in its rRNA. doi:10.1111/cmi.13199 names it Cell Microbiol 2020
Second Line Injectable Drug Resistance and Associated Genetic Mutations in Newly Diagnosed Cases of Multidrug-Resistant Tuberculosis. doi:10.1089/mdr.2019.0215 Microb Drug Resist 2020
Recombinant polypeptide of Mycobacterium leprae as a potential tool for serological detection of leprosy. doi:10.1186/s13568-019-0928-9 AMB Express 2019
Prevalence, risk and genetic characteristics of drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China. doi:10.2147/IDR.S209971 Infect Drug Resist 2019
Mutation and Transmission Profiles of Second-Line Drug Resistance in Clinical Isolates of Drug-Resistant Mycobacterium tuberculosis From Hebei Province, China. doi:10.3389/fmicb.2019.01838 Front Microbiol 2019
Assessing capreomycin resistance on tlyA deficient and point mutation (G695A) Mycobacterium tuberculosis strains using multi-omics analysis. doi:10.1016/j.ijmm.2019.06.003 names it Int J Med Microbiol 2019
Identification of virulence and antibiotic resistance factors in Arcobacter butzleri isolated from bovine milk by Whole Genome Sequencing. doi:10.4081/ijfs.2019.7840 Ital J Food Saf 2019
Integrating informatics tools and portable sequencing technology for rapid detection of resistance to anti-tuberculous drugs. doi:10.1186/s13073-019-0650-x Genome Med 2019
Second-line anti-tuberculosis drug resistance testing in Ghana identifies the first extensively drug-resistant tuberculosis case. doi:10.2147/IDR.S152720 Infect Drug Resist 2018
Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco. doi:10.1186/s12879-018-3009-9 BMC Infect Dis 2018
A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study. doi:10.1016/S1473-3099(18)30004-5 Lancet Infect Dis 2018
FIND Tuberculosis Strain Bank: a Resource for Researchers and Developers Working on Tests To Detect Mycobacterium tuberculosis and Related Drug Resistance. doi:10.1128/JCM.01662-16 J Clin Microbiol 2017
A Novel Motif for S-Adenosyl-l-methionine Binding by the Ribosomal RNA Methyltransferase TlyA from Mycobacterium tuberculosis. doi:10.1074/jbc.M116.752659 names it J Biol Chem 2017
Molecular Investigation of Resistance to Second-Line Injectable Drugs in Multidrug-Resistant Clinical Isolates of Mycobacterium tuberculosis in France. doi:10.1128/AAC.01299-16 Antimicrob Agents Chemother 2017
Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates from high prevalence tuberculosis states in Mexico. doi:10.1016/j.meegid.2016.09.012 Infect Genet Evol 2017
TlyA protein of Mycobacterium leprae: a probable bio-marker of active infection. names it Lepr Rev 2016
Nonmutational compensation of the fitness cost of antibiotic resistance in mycobacteria by overexpression of tlyA rRNA methylase. doi:10.1261/rna.057257.116 names it RNA 2016
Molecular analysis of genetic mutations among cross-resistant second-line injectable drugs reveals a new resistant mutation in Mycobacterium tuberculosis. doi:10.1016/j.diagmicrobio.2016.05.010 Diagn Microbiol Infect Dis 2016
Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant Mycobacterium tuberculosis clinical isolates. doi:10.1016/j.jmii.2015.04.003 J Microbiol Immunol Infect 2016
Mycobacterial tlyA gene product is localized to the cell-wall without signal sequence. doi:10.3389/fcimb.2015.00060 names it Front Cell Infect Microbiol 2015
Mycobacterium tuberculosis TlyA Protein Negatively Regulates T Helper (Th) 1 and Th17 Differentiation and Promotes Tuberculosis Pathogenesis. doi:10.1074/jbc.M115.653600 names it J Biol Chem 2015
[Resistance to second-line anti-tuberculosis drugs among peruvian multidrug resistant Mycobacterium tuberculosis strains]. Rev Peru Med Exp Salud Publica 2014
Modulation of phagolysosome maturation by bacterial tlyA gene product. doi:10.1007/s12038-014-9472-6 names it J Biosci 2014
Characterization of extensively drug-resistant Mycobacterium tuberculosis isolates circulating in Siberia. doi:10.1186/1471-2334-14-478 BMC Infect Dis 2014
Genome analysis of 17 extensively drug-resistant strains reveals new potential mutations for resistance. doi:10.1128/genomeA.00759-14 Genome Announc 2014
Molecular characterization of amikacin, kanamycin and capreomycin resistance in M/XDR-TB strains isolated in Thailand. doi:10.1186/1471-2180-14-165 BMC Microbiol 2014
Molecular and phenotypic characterization of multidrug-resistant Mycobacterium tuberculosis isolates resistant to kanamycin, amikacin, and capreomycin in China. doi:10.1007/s10096-014-2144-5 Eur J Clin Microbiol Infect Dis 2014
Characterization of a novel mutation in the overlap of tlyA and ppnK involved in capreomycin resistance in Mycobacterium. doi:10.1002/iub.1277 names it IUBMB Life 2014
Prediction of XDR/pre-XDR tuberculosis by genetic mutations among MDR cases from a hospital in Shandong, China. doi:10.1016/j.tube.2014.03.005 Tuberculosis (Edinb) 2014
Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Hunan, China. doi:10.1128/AAC.02426-14 Antimicrob Agents Chemother 2014
Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates from China. doi:10.1128/AAC.01792-13 Antimicrob Agents Chemother 2014
Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutations. doi:10.1128/JCM.02701-13 J Clin Microbiol 2014
Geographical differences associated with single-nucleotide polymorphisms (SNPs) in nine gene targets among resistant clinical isolates of Mycobacterium tuberculosis. doi:10.1128/JCM.00857-13 J Clin Microbiol 2014
Mycobacterium tuberculosis rrs A1401G mutation correlates with high-level resistance to kanamycin, amikacin, and capreomycin in clinical isolates from mainland China. doi:10.1016/j.diagmicrobio.2013.06.031 Diagn Microbiol Infect Dis 2013
Increased bacterial hemolytic activity is conferred by expression of TlyA methyltransferase but not by its 2'-O-methylation of the ribosome. doi:10.1007/s00284-013-0332-7 names it Curr Microbiol 2013
Molecular genetics of Mycobacterium tuberculosis resistant to aminoglycosides and cyclic peptide capreomycin antibiotics in Korea. doi:10.1007/s11274-013-1256-x World J Microbiol Biotechnol 2013
From multidrug-resistant to extensively drug-resistant tuberculosis in Lisbon, Portugal: the stepwise mode of resistance acquisition. doi:10.1093/jac/dks371 J Antimicrob Chemother 2013
Mycobacterium leprae virulence-associated peptides are indicators of exposure to M. leprae in Brazil, Ethiopia and Nepal. doi:10.1590/s0074-02762012000900018 Mem Inst Oswaldo Cruz 2012
Capreomycin susceptibility is increased by TlyA-directed 2'-O-methylation on both ribosomal subunits. doi:10.1111/j.1365-2958.2012.08168.x names it Mol Microbiol 2012
Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review. doi:10.1371/journal.pone.0033275 PLoS One 2012
Evaluation of the GenoType® MTBDRsl assay for susceptibility testing of second-line anti-tuberculosis drugs. doi:10.5588/ijtld.10.0600 Int J Tuberc Lung Dis 2012
Mutations in the rrs A1401G gene and phenotypic resistance to amikacin and capreomycin in Mycobacterium tuberculosis. doi:10.1089/mdr.2011.0063 Microb Drug Resist 2012
Isolation of conditional expression mutants in Mycobacterium tuberculosis by transposon mutagenesis. doi:10.1016/j.tube.2011.07.004 Tuberculosis (Edinb) 2011
Structural and functional characterization of Rv2966c protein reveals an RsmD-like methyltransferase from Mycobacterium tuberculosis and the role of its N-terminal domain in target recognition. doi:10.1074/jbc.M110.200428 J Biol Chem 2011
Molecular modeling and in silico characterization of Mycobacterium tuberculosis TlyA: possible misannotation of this tubercle bacilli-hemolysin. doi:10.1186/1472-6807-11-16 names it BMC Struct Biol 2011
Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosis. doi:10.1093/jac/dkr109 names it J Antimicrob Chemother 2011
Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis. doi:10.1128/AAC.01550-10 Antimicrob Agents Chemother 2011
[The effects of gene mutation related to drug resistance and drug efflux pump in extensively drug-resistant tuberculosis clinical isolates]. Zhonghua Jie He He Hu Xi Za Zhi 2010
Molecular characterization of tlyA gene product, Rv1694 of Mycobacterium tuberculosis: a non-conventional hemolysin and a ribosomal RNA methyl transferase. doi:10.1186/1471-2091-11-35 names it BMC Biochem 2010
Usefulness of resistant gene markers for predicting treatment outcome on second-line anti-tuberculosis drugs. doi:10.1111/j.1365-2672.2010.04840.x J Appl Microbiol 2010
Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates. doi:10.1128/JCM.01947-09 J Clin Microbiol 2010
Genetic analysis of extensively drug-resistant Mycobacterium tuberculosis strains in Lisbon, Portugal. doi:10.1093/jac/dkp452 J Antimicrob Chemother 2010
High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene. doi:10.1128/AAC.00851-09 Antimicrob Agents Chemother 2009
Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment. doi:10.1128/AAC.00050-09 Antimicrob Agents Chemother 2009
Functional analysis of the Campylobacter jejuni cj0183 and cj0588 genes. doi:10.1007/s00284-008-9130-z Curr Microbiol 2008
Rapid recombination screening to test gene essentiality demonstrates that pyrH is essential in Mycobacterium tuberculosis. doi:10.1016/j.tube.2007.05.015 Tuberculosis (Edinb) 2007
Identification of the biosynthetic gene cluster and an additional gene for resistance to the antituberculosis drug capreomycin. doi:10.1128/AEM.00485-07 Appl Environ Microbiol 2007
Capreomycin binds across the ribosomal subunit interface using tlyA-encoded 2'-O-methylations in 16S and 23S rRNAs. doi:10.1016/j.molcel.2006.05.044 names it Mol Cell 2006
Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis. doi:10.1128/AAC.49.8.3192-3197.2005 Antimicrob Agents Chemother 2005
Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis. doi:10.1128/AAC.49.2.571-577.2005 names it Antimicrob Agents Chemother 2005
Brachyspira hyodysenteriae and other strongly beta-haemolytic and indole-positive spirochaetes isolated from mallards (Anas platyrhynchos). doi:10.1099/jmm.0.05488-0 J Med Microbiol 2004
Helicobacter pylori pore-forming cytolysin orthologue TlyA possesses in vitro hemolytic activity and has a role in colonization of the gastric mucosa. doi:10.1128/IAI.69.3.1697-1703.2001 names it Infect Immun 2001
Use of a flexible cassette method to generate a double unmarked Mycobacterium tuberculosis tlyA plcABC mutant by gene replacement. doi:10.1099/00221287-146-8-1969 names it Microbiology (Reading) 2000
Enhanced gene replacement in mycobacteria. doi:10.1099/13500872-145-3-519 Microbiology (Reading) 1999
Characterization of a haemolysin from Mycobacterium tuberculosis with homology to a virulence factor of Serpulina hyodysenteriae. doi:10.1099/00221287-144-5-1205 Microbiology (Reading) 1998

Title+abstract index only: a paper that names this gene solely in its body text, a figure legend or a supplement is invisible here. That is why this list sits beside the curated layer rather than replacing it - Rv0007's characterisation, found by a full-text sweep, returns zero in this one. Absence from this list is not absence from the literature. Source: PubMed E-utilities sweep (esearch + esummary), every alias of the gene searched in conjunction with a mycobacterial context term; ambiguous common-word aliases excluded. phase198, 2026-09-06.

This layer CITES the literature and adds context; it does not change the verdict or the function stated elsewhere in this fiche. This distinguishes a gene that is dark because nobody has looked from one that is dark despite having been studied. Source: PubMed (whole): H37Rv locus tag + GENE NAME + ortholog identifiers (Mb…, MMAR_…, MSMEG_…, ML…, MAB_…), under a mycobacterial context filter; hits verified against the abstract text. Species-context counts distinguish M. tuberculosis literature from literature on other mycobacteria. phase76/phase77, 2026-07-13.

Genomic-neighbour overlap (structural caveat) co-directional · 0 % of gene

NeighbournadK (Rv1695, + strand)
Overlap1 bp, 0 % of this gene's length

co-directional overlap: ordinary (e.g. shared stop/start codons in an operon), not the Rv2438A-type artefact P20.1, derived from GFF3 gene coordinates, 2026-08-03.

CRISPRi vulnerability

Vulnerability index -3.13 (95% CI -9.11 to 3.94). A more negative index = more vulnerable to knockdown (better drug-target quality); indicative threshold VI ≤ -6 = highly vulnerable.

Quantitative CRISPRi knockdown, graded (finer than binary Tn-seq essentiality). Source: CRISPRi vulnerability index (Bosch 2021, supplementary Table S2 'mmc3.xlsx', bulk import via Europe PMC -- supersedes the per-gene pebble.rockefeller.edu scrape of phase46_crispri_vulnerability.py).

Caveat on this estimate. Bosch et al. flag this gene's vulnerability estimate as NOT certain, and here that call has a mechanical cause visible in the library itself: every guide targeting this gene is >=21 nt (str_span=0.320 on a 0-1 scale, near the genome floor), and guide repression strength saturates from 21 nt on -- so the library never sampled a partial knockdown for this gene, only the near-maximal repression plateau. The dose-response fit (and this VI) is therefore essentially unconstrained by data, not merely uncertain -- a limitation of the CRISPRi library design for the non-essential class (Bosch et al. 2021), not a defect in this specific measurement. n_guides=7 is descriptive only and does not predict this. Do not cite this VI as a standalone vulnerability claim.

Legacy record & comparison (Mycobrowser)

Mycobrowser functionMethylates 16S and 23S rRNA. Also has contact-dependent haemolytic activity; possibly involved in virulence (pore formation).

The legacy Mycobrowser record is shown for verification. Mycobrowser is no longer maintained; its EC numbers predate recent nomenclature revisions, so a class change usually reflects re-numbering, not a conflict.

Orthologues (reciprocal best hits across mycobacteria)

M. bovis Mb1720 · 99.6% identity
M. leprae ML1358 · 78.7% identity
M. marinum MMAR_2499 · 81.3% identity
M. smegmatis MSMEG_3751 · 76.5% identity
M. orygis RJtmp_001771 · 99.6% identity
M. abscessus MAB_2359 · 69.4% identity

Reciprocal-best-hit orthologues (DIAMOND) against the Mycobrowser reference proteomes. A missing species is informative: e.g. a gene absent from M. leprae was likely lost in its reductive genome evolution. Locus tags link to Mycobrowser.

Curated reference (UniProt)

UniProt P9WJ63 SwissProt · reviewed · Evidence at protein level
UniProt name16S/23S rRNA
EC (curated) EC 2.1.1.226, EC 2.1.1.227
Curated functionActs as a host evasion factor, that significantly contributes to the pathogenesis of M.tuberculosis by modulating adaptive immune responses by inhibiting host-protective Th1 and Th17 cytokine responses as well as autophagy. Catalyzes the 2'-O-methylation at nucleotides C1409 in 16S rRNA and C1920 in 23S rRNA. Is likely involved in ribosomal biogenesis. Also exhibits hemolytic activity in vitro, by binding with and oligomerizing into host cell membranes.

Functional vocabulary (eggNOG-mapper, orthology transfer)

COG category J Translation, ribosomal structure and biogenesis
Preferred nametlyA
eggNOG descriptionHemolysin TlyA
Orthologous groupCOG1189
EC number EC 2.1.1.226, EC 2.1.1.227
KEGG orthology K06442
Gene Ontology (65) GO:0000154, GO:0001510, GO:0001897, GO:0001906, GO:0001907, GO:0003674, GO:0003824, GO:0006139, GO:0006364, GO:0006396, GO:0006725, GO:0006807 +53 more

Orthology-based transfer (eggNOG 5.0.2, diamond). EC/KO/GO/CAZy are computed annotations, not manual curation; cross-check against the primary literature before treating a specific reaction as established.

Conservation & selection (intra-MTBC, 142 601 strains, snapshot of 2026-09-29)

pN/pS 0.588 · quasi-invariant (5 sites), pN/pS underpowered
Polymorphic sites (≥ 0.1% of strains) 2 synonymous, 3 missense, 0 nonsense, 0 frameshift

pN/pS from segregating SNPs (singletons removed) normalised by possible sites. Low pN/pS = purifying selection (a strong signal that a "hypothetical" is a real, constrained gene). A high pN/pS is ambiguous: relaxed constraint or positive selection (drug resistance, antigenic variation) inflate it; e.g. rpoB/katG/pncA score high here for resistance, not loss of function. A clonal disruption (one allele over a clade) suggests lineage pseudogenisation; a convergent one (many independent alleles) is typical of resistance loss-of-function.

Outgroup conservation (beyond the MTBC) Bacteria

M. canettii dN/dS (deep-divergence selection) 0.0 (low power) · 1 consensus substitution(s)
low power (1 canettii-consensus substitution(s)); present in M. canettii but dN/dS not reliable
Limitation: dN/dS mixes fixed canettii-H37Rv divergence with intra-canettii polymorphism, and is not polarised (the per-gene repolarisation is not viable: 79 % of the consensus SPDI lie outside the polarised table).
Genus-wide presence (~53 non-MTBC Mycobacterium) present in 53/53 (100%) · mean identity 80.5% · 4/4 closest MTBAP relatives
conserved across the genus (present in 53/53 non-MTBC Mycobacterium genomes, incl. distant relatives) — an ancient core gene predating the genus radiation
Phylostratum (deepest detected homolog) MTBC-specific → Mycobacterium → Mycobacteriaceae → Corynebacteriales → Actinomycetia → Bacteria
detected in 12/13 non-Mycobacterium reference genomes (down to Bacteria) · mean identity 56.3%
detected down to outside the phylum (Proteobacteria/Firmicutes controls) — a universally conserved, ancient bacterial gene

Two orthogonal outgroup signals. M. canettii (the immediate outgroup) gives a deep-divergence dN/dS (a low value confirms a constrained, real gene; shown as confident only at ≥8 substitutions, else flagged low-power). Genus-wide presence/absence (tblastn vs assembled non-MTBC genomes) places the gene on the ancient-core ↔ MTBC-specific axis: a gene absent even from the closest MTBAP relatives is a candidate MTBC-specific innovation (possible host-adaptation factor, to confirm by synteny). The phylostratum extends that axis outside the genus (tblastn vs 13 reference genomes spanning Mycobacteriaceae → Corynebacteriales → Actinomycetia → outside the phylum): it is the deepest clade in which a homolog is still detected, i.e. a proxy for gene age. Read it with the null model in mind: a shallow (young) stratum can also reflect homology-detection failure for short or fast-evolving ORFs, so it is a descriptive axis, not a proof of novelty.

Essentiality (transposon mutagenesis)

The two screens disagree on this gene: Tn-seq says non-essential (NE), CRISPRi says essential, with an estimate its own authors flag as not certain.

Two genome-wide screens disagree on this gene, and both are kept as they stand. They do not measure the same thing: the Tn-seq call (DeJesus 2017) reports tolerance to transposon insertion across the ORF, the CRISPRi call (Bosch 2021) reports tolerance to partial knockdown. A gene can absorb an insertion and still be required at full dosage, or the reverse. Here the CRISPRi estimate is one its own authors flag as NOT certain (vulnerability index -3.128), so it is the weaker of the two calls. Do not treat the CRISPRi essentiality as settled here. Atlas-wide, 104 gene(s) fall in this exact stratum, out of 193 showing this direction of disagreement.

DeJesus 2017 callNE · non-essential
What the call meansnon-essential
TA sites (Himar1) 11 in the ORF — 1 in the essential state, 0 growth-defect, 10 non-essential, 0 growth-advantage. Saturation 0.727, mean read count 35.625. A region of the protein devoid of TA sites is invisible to this assay: nothing can be inferred about it, in either direction.
All 11 sites lie in this ORF alone (no overlapping CDS shares any), so the call is attributable to this gene.

Genome-wide Himar1 transposon essentiality in H37Rv (DeJesus 2017). An essential call (ES/ESD/GD) is strong, independent evidence that a "hypothetical" locus encodes a functional, selectively required gene — orthogonal to intra-species conservation.

Drug resistance (WHO catalogue) capreomycin

capreomycin342 catalogued resistance-associated variant(s)

This gene carries mutations classed Associated with resistance (WHO grade 1–2) in the consolidated catalogue (WHO 2nd ed. 2023 + tb-profiler). Only the R-associated tier is shown; "uncertain" and empirical-only signals are excluded. Test a specific strain or variant with the resistance tester. Research context, not a clinical diagnostic.

Proteomics (mass spectrometry) detected

MS detectiondetected in 8 of 16 independent MS datasets
Integrated abundance3.88 ppm · rank 3023/3519 (14.1th percentile)

Detection by mass spectrometry is direct, experimental evidence that the protein product exists — orthogonal to sequence conservation and to Tn-seq essentiality, and especially decisive for a "hypothetical" locus. Read the dataset count as abundance, not as replication. Measured across this atlas (3,491 detected proteins), the number of datasets a protein appears in tracks its abundance almost monotonically: median 1.2 ppm at 1 dataset of 16, 27 ppm at 10, 392 ppm at 15, 1,325 ppm at 16 — three orders of magnitude. A high count therefore says the protein is abundant more than it says several independent experiments confirmed it. What the count does establish, at any value, is that the product exists.

Predicted localisation (DeepTMHMM + lipobox) no export signal, no TM helix

Predictionno signal peptide, no TM helix (DeepTMHMM class GLOB)
DeepTMHMM classGLOB

A verified absence of signals, which is not a compartment. No Sec/Tat signal peptide, no transmembrane helix and no lipobox were found on this sequence. The predictor reports topology and export signals; it does not measure where the protein ends up, so this page draws no cytoplasmic conclusion from it. In M. tuberculosis that reservation is not theoretical: the 12 Esx paralogues of this atlas — EsxA/ESAT-6 and EsxB/CFP-10 among them, the best-established secreted proteins of the species — carry this very call, because substrates of the type VII (ESX) secretion system leave no recognisable signal. « Secreted » and « no signal peptide » are true together here.

Transmembrane topology and signal peptide from DeepTMHMM (deep-learning reference predictor); lipoproteins from a (myco)bacterial lipobox motif. A sequence-based prediction of subcellular context.

Physico-chemical properties (computed, ProtParam)

Length268 aa
Molecular weight28.1 kDa
Theoretical pI9.74
GRAVY0.088 (hydrophobic)
Aliphatic index103.0
Aromaticity0.041
Instability index32.6 (stable)

Computed from the ancestral MTBC0 sequence with the ExPASy ProtParam method (Biopython). Descriptive biophysical context: a positive GRAVY flags a hydrophobic (often membrane) protein, a high instability index (>40) predicts a short in-vitro half-life, an extreme pI hints at compartment or binding partner.

Domains (Pfam, hmmscan --cut_ga)

PfamAccessioni-EvalueResiduesDescription
S4PF01479.31 3.1e-076–47 S4 domain
FtsJPF01728.26 1.4e-4562–244 FtsJ-like methyltransferase

3D structure (interactive — Mol*/pdbe-molstar)

Experimental structure 7s0s (PDBe), the strongest available structural evidence for this gene. Drag to rotate, scroll to zoom; hetero-groups (ligands, ions, waters hidden by default) shown as sticks.

Experimental structures (Protein Data Bank) 3 solved

PDBMethodResolutionCoverage
7s0s Electron Microscopy 3.05 Å 100%
5kyg X-ray diffraction 1.9 Å 78%
5ks2 X-ray diffraction 2.18 Å 78%

Experimentally solved structures mapped from the UniProt accession via PDBe/SIFTS (3 total; up to 8 shown, ranked by sequence coverage then resolution). An experimental structure is direct proof of the folded product and the strongest structural evidence — superseding the predicted ESMFold/AlphaFold models below for any covered region.

Structural search (AlphaFold DB model, Foldseek vs PDB — genome-wide) pLDDT 93.5

PDB hitprobTM (aln)TM (query)TM (target)Seq. id.Cov. q / tE-valueDescription
5eov-assembly1_A 1.00 0.99 0.76 0.99 100% 76% / 100% 2.6e-39 sig 5eov-assembly1_A C-terminal domain of the 16S/23S rRNA (cytidine-2'-O)-methyltransferase TlyA.
7s0s-assembly1_B 1.00 0.79 0.78 0.78 100% 98% / 100% 5.0e-39 sig 7s0s-assembly1_B M. tuberculosis ribosomal RNA methyltransferase TlyA bound to M. smegmatis 50S ribosomal subunit
3hp7-assembly1_A 1.00 0.81 0.81 0.79 36% 99% / 98% 6.8e-28 sig 3hp7-assembly1_A Putative hemolysin from Streptococcus thermophilus.
3opn-assembly1_A 1.00 0.92 0.70 0.90 39% 75% / 97% 6.2e-23 sig 3opn-assembly1_A The crystal structure of a putative hemolysin from Lactococcus lactis
2fpo-assembly1_A 1.00 0.65 0.44 0.65 16% 73% / 93% 6.9e-08 sig 2fpo-assembly1_A Putative methyltransferase yhhF from Escherichia coli.

Foldseek search of the AlphaFold DB model (mean pLDDT 93.5, gated at 70) against the PDB — a genome-wide extension of the ESMFold dark-gene search that also covers proteins beyond the single-sequence length limit. Confident structural neighbours (E < 0.01) shown.

Genomic context (neighbours & predicted operon) operon of 7

Upstream (5' on genome)Rv1693 (+ strand, 7 bp gap)
Downstream (3' on genome)ppnK (+ strand, -1 bp gap)
Predicted operon lprJ · Rv1691 · Rv1692 · Rv1693 · tlyA · ppnK · recN

Neighbours from the H37Rv annotation (+ strand). The operon is predicted by co-directional intergenic distance (same strand, gaps ≤50 bp) — a transcription-unit hypothesis, not a mapped TSS. For a "hypothetical", co-transcription with a characterised operon is a concrete functional lead (complements the STRING neighborhood channel below).

Published operon evidence (two independent sources)

Roback 2007 (logistic regression: distance + expression correlation, 474 microarrays) operon of 5: tlyA · ppnK · recN · Rv1697 · mctB — disagrees with the distance heuristic above
REMap 2016 (RNA-seq coverage continuity, CDC1551, tag MT1733) exponential phase: operon of 8, Rv1689 · Rv1690 · Rv1691 · Rv1692 · Rv1693 · Rv1694 · Rv1695 · Rv1696 (coverage 37.48)
not expressed (stationary phase) — disagrees with the distance heuristic above

Two independent published operon maps, cited alongside the distance heuristic above: an association corroborating or contradicting the heuristic, never proof of shared function. REMap's RNA-seq coverage continuity is the most direct of the three signals; Roback's logistic regression and the intergenic-distance heuristic are statistical proxies.

Functional interaction network (STRING v12, guilt-by-association)

Explore full network →

Node colour = verdict, dashed = still uncharacterised; edge colour = evidence (green experimental, orange genomic-context, grey co-expression), width ∝ score. Click a partner to open its page; "Explore full network" to walk the graph.

Closest characterised functional partner: ppnK (inorganic polyphosphate/ATP-NAD kinase), high confidence (score 938, all STRING channels except text-mining; the partner is chosen on its genomic-context evidence).

Showing the 15 strongest of this gene's 61 partners at medium confidence (26 at high confidence). The table is an extract, not a neighbourhood: across the proteome the real median degree is 34 while the served median is 15, so no hub, degree distribution or centrality may be read on this table. None of the 61 partners rests on an interaction measured in M. tuberculosis itself.

PartnerProductScoreNo text-miningChannels (≥400)
Rv1695 ppnK inorganic polyphosphate/ATP-NAD kinase 986 938 ctx neighborhood:882 coexpression:494 textmining:790
Rv1696 recN DNA repair protein RecN 917 895 ctx neighborhood:867
Rv1691 hypothetical protein 946 886 ctx neighborhood:882 textmining:548
Rv1693 dark hypothetical protein 945 883 ctx neighborhood:882 textmining:548
Rv1692 phosphatase 944 882 ctx neighborhood:882 textmining:548
Rv1697 steA hypothetical protein 768 768 ctx neighborhood:766
Rv1698 mctB copper transporter MctB 750 750 ctx neighborhood:748
Rv1690 lprJ lipoprotein LprJ 732 733 ctx neighborhood:732
Rv1700 NUDIX hydrolase 657 657 ctx neighborhood:648
Rv0668 rpoC DNA-directed RNA polymerase subunit beta' 784 651 coexpression:647 textmining:407
Rv1701 xerD tyrosine recombinase XerD 646 646 ctx neighborhood:625
Rv1699 pyrG CTP synthase 670 629 ctx neighborhood:627
Rv2682c dxs1 1-deoxy-D-xylulose 5-phosphate synthase 469 469 coexpression:439
Rv3379c dxs2 1-deoxy-D-xylulose-5-phosphate synthase 455 455 coexpression:424
Rv1007c metS methionine--tRNA ligase 440 441 ctx cooccurence:409

STRING combines evidence channels (neighborhood, fusion, cooccurrence, coexpression, experimental, database, text-mining) into a 0–1000 score. The ctx badge marks edges carried by the genomic-context channels (conserved neighborhood, fusion, phylogenetic co-occurrence), which are independent of orthology and structure and the strongest signal for an unknown gene. The no text-mining column recomputes the score from data alone, so a link that does not depend on the literature is visible. Association is a function hypothesis, not proof: corroborate with the operon context and the primary literature before assigning a function.

Where the experimental evidence comes from, and why it matters here. STRING's experimental channel fuses interactions measured in M. tuberculosis with interactions measured in another organism and transferred to this pair by orthology. The two are not equivalent for this atlas, whose standing rule is that better studied elsewhere is not a function established in M. tuberculosis. Measured on the served network: of the 38 229 partner pairs shown across the atlas, 13 483 partner rows carry a non-zero experimental channel, and only 106 pairs rest on an interaction measured in M. tuberculosis itself — 0.3 % of the network. Those 106 are long-established complexes (ESX-1/ESAT-6, RNA polymerase with CarD and RbpA, the Pup–Mpa proteasome, gyrase, Emb, GarA with PknB and PknG, the Rel modules); no still-uncharacterised gene is among them. The reason is not a gap in this atlas but in the literature: there is almost no experimental interactome of this bacterium, IntAct holding 134 curated protein pairs for a ~4 000-gene proteome. A exp (transferred) badge is therefore a lead, never a measurement, and an absence of badge is not evidence that the pair does not interact.

Evidence

  • Legacy H37Rv annotation: 16S/23S rRNA (cytidine-2'-O)-methyltransferase TlyA
  • MTBC0 PGAP product: 16S/23S rRNA (cytidine-2'-O)-methyltransferase TlyA
  • Pfam (hmmscan --cut_ga): S4 PF01479.31 (E=3e-07), FtsJ PF01728.26 (E=1e-45)
  • (auto-curated by rules from PGAP + Pfam + Foldseek; not hand-reviewed)

Sources

  • Ancestral sequence & coordinates: Harrison LB et al. (2024), An imputed ancestral reference genome for the MTBC, doi:10.1101/2023.09.07.556366
  • Product annotation: NCBI PGAP on MTBC0; legacy from H37Rv NC_000962.3 (RefSeq NP_216210.1)
  • Domains: Pfam-A via hmmscan --cut_ga — S4 (PF01479.31), FtsJ (PF01728.26)
  • Sequence-level signal: ESM Atlas (EvolutionaryScale × BioHub) — exploratory
  • Controlled vocabulary: eggNOG-mapper 2.1.12 (Cantalapiedra et al. 2021, doi:10.1093/molbev/msab293), eggNOG 5.0 DB (Huerta-Cepas et al. 2019) — OG COG1189
  • Curated reference: UniProt P9WJ63 (SwissProt, reviewed; Evidence at protein level)
  • Intra-MTBC selection: pN/pS and disruption from SPDI variants of 142 601 MTBC strains (this work, local collection vs H37Rv NC_000962.3)
  • Genome-wide structure: AlphaFold DB model (Jumper et al. 2021, doi:10.1038/s41586-021-03819-2; Varadi et al. 2024, doi:10.1093/nar/gkad1011) searched vs PDB with Foldseek (mean pLDDT 93.5)
  • Interaction network: STRING v12.0 (Szklarczyk et al. 2023, doi:10.1093/nar/gkac1000), taxon 83332, CC-BY 4.0 — 61 functional partner(s); context anchor ppnK
  • Essentiality: genome-wide transposon mutagenesis in H37Rv — DeJesus et al. 2017 (mBio, doi:10.1128/mBio.02133-16, CC BY)
  • Proteomics: integrated mass-spectrometry abundance from PaxDb 5.0 (Huang et al. 2023, doi:10.1016/j.mcpro.2023.100640), taxon 83332 — weighted average of 16 datasets, incl. Schubert et al. 2013 (doi:10.1016/j.chom.2013.04.008) and Albrethsen et al. 2013 (doi:10.1074/mcp.M112.018846)
  • Functional category: TubercuList scheme (Cole et al. 1998, doi:10.1038/31159), via Mycobrowser (Kapopoulou et al. 2011, doi:10.1016/j.tube.2010.09.006)
  • Orthologues: reciprocal best hits (DIAMOND, Buchfink et al. 2021, doi:10.1038/s41592-021-01101-x) against Mycobrowser release 5 reference proteomes
  • Experimental structures: PDBe/SIFTS UniProt→PDB mapping (Dana et al. 2019, doi:10.1093/nar/gky1114)
  • Genomic context / operon: H37Rv annotation; operon predicted by co-directional intergenic distance (Salgado et al. 2000, doi:10.1073/pnas.030539397)
  • Drug resistance: consolidated catalogue, WHO 2nd ed. 2023 (9789240082410) + tb-profiler; only the resistance-associated tier (grade 1–2) is surfaced
  • Physico-chemical properties: ExPASy ProtParam method via Biopython (Gasteiger et al. 2005), computed from the MTBC0 sequence
  • Predicted localisation: DeepTMHMM (Hallgren et al. 2022, doi:10.1101/2022.04.08.487609) for transmembrane topology and signal peptide
  • Primary literature: none located yet; annotation rests on the domain/homology sources above.

Ancestral MTBC0 protein sequence

>mtbc0_001802|Rv1694|tlyA
MARRARVDAELVRRGLARSRQQAAELIGAGKVRIDGLPAVKPATAVSDTTALTVVTDSERAWVSRGAHKLVGALEAFAIAVAGRRCLDAGASTGGFTEVLLDRGAAHVVAADVGYGQLAWSLRNDPRVVVLERTNARGLTPEAIGGRVDLVVADLSFISLATVLPALVGCASRDADIVPLVKPQFEVGKGQVGPGGVVHDPQLRARSVLAVARRAQELGWHSVGVKASPLPGPSGNVEYFLWLRTQTDRALSAKGLEDAVHRAISEGP